Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia

Inclusion Criteria

• •Female sex
• •Aged 18 years old or older
• •Diagnosed with Stage 0-III hormone receptor positive breast cancer
• •Completed primary cancer treatment (surgery, chemotherapy, and/or radiation therapy)
• •Postmenopausal
• •Currently taking AI therapy (letrozole, exemestane, or anastrozole)
• •Reporting musculoskeletal pain that developed or worsened since starting AI therapy
• •Reporting at least 15 days of pain in the past 30 days
• •A worst pain rating of 4 or more on an 11 point (0-10) numerical rating scale in the past week
• •Based on known factors affecting their prognosis, patient is likely to be able to complete the study protocol
• •ECOG performance status of 0-2
• •English proficient
• •If participants are taking analgesics, they must be on a stable analgesic regimen for at least 14 days prior to enrollment and should not have planned upward dose titration of their analgesics during the study period. (Note: Patients may elect to decrease their analgesic use during the study as per discussion with their provider. Unexpected dose adjustments including dose escalations due to unforeseen clinical need is allowed. Cannabis taken for pain relief would qualify as an analgesic)
• •Comfortable using a tablet computer, a computer, or a smartphone to access online training